Search Results - jessica+thaxton

1 Results Sort By:
Applying PERK/ERO1α inhibitors to modulate T cell metabolism to augment cancer immunotherapy
Technology: A MUSC researcher has identified a novel immune-based therapy to treat cancer by targeting the PERK pathway using ERO1α antagonists combined with immune checkpoint blockade or Adoptive T-Cell (ACT) therapies. Data gathered demonstrates that either a PERK or ERO1α inhibitor combined with anti-PD-1 or ACT has a superior therapeutic...
Published: 3/23/2019   |   Inventor(s): Jessica Thaxton
Category(s): Therapeutic
© 2021. All Rights Reserved. Powered by Inteum